Moderna's Algorithm May Be Key to Personalized Cancer Vaccine Success
Source Summary
Moderna and Merck have developed a personalized cancer vaccine that may represent a breakthrough in immunology and cancer biology. The vaccine's success may depend significantly on an algorithm developed by the companies.
Why it matters
The algorithm's role in the vaccine's development demonstrates how computational methods may be critical to advancing personalized cancer treatments.
